Integration of Factor Xa Inhibitors into Oncology Protocols for...

added blog Health

2025-12-17 12:44:11 -

Integration of Factor Xa Inhibitors into Oncology Protocols for Cancer-Associated Thrombosis

Cancer patients face a significantly higher risk of venous thromboembolism (VTE) due to the pro-coagulant nature of malignant cells and the side effects of various chemotherapy regimens. Use cases in the oncology industry segment have historically relied on injectable low-molecular-weight heparins. However, recent clinical evidence has paved the way for oral Factor Xa inhibitors as a preferred...

0 Comments 0 Shares 74 Views 0 Reviews